1. Home
  2. RMD vs STLA Comparison

RMD vs STLA Comparison

Compare RMD & STLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$253.15

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Logo Stellantis N.V.

STLA

Stellantis N.V.

HOLD

Current Price

$9.37

Market Cap

32.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMD
STLA
Founded
1989
2021
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
36.4B
32.7B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
RMD
STLA
Price
$253.15
$9.37
Analyst Decision
Buy
Buy
Analyst Count
12
5
Target Price
$291.10
$12.49
AVG Volume (30 Days)
880.0K
11.5M
Earning Date
01-29-2026
02-25-2026
Dividend Yield
0.93%
6.02%
EPS Growth
29.59
N/A
EPS
9.77
N/A
Revenue
$5,257,400,000.00
$171,605,402,237.00
Revenue This Year
$9.85
$0.20
Revenue Next Year
$7.34
$5.45
P/E Ratio
$26.36
N/A
Revenue Growth
9.36
N/A
52 Week Low
$199.92
$8.39
52 Week High
$293.81
$14.28

Technical Indicators

Market Signals
Indicator
RMD
STLA
Relative Strength Index (RSI) 53.46 27.66
Support Level $240.00 $10.07
Resistance Level $261.36 $11.32
Average True Range (ATR) 5.40 0.24
MACD 1.27 -0.19
Stochastic Oscillator 60.56 2.09

Price Performance

Historical Comparison
RMD
STLA

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

About STLA Stellantis N.V.

Stellantis was created out of the merger of US-based Fiat Chrysler Automobiles and French-based Peugeot in January 2021, resulting in the fourth-largest automotive original equipment manufacturer by vehicle sales. In 2024 it sold 5.5 million vehicles, 47%, 26% and 17% in Europe, North America, and South America, respectively. Its brands include Fiat, Jeep, Chrysler, Ram, Peugeot, Citroën, Opel, Alfa Romeo, and Maserati.

Share on Social Networks: